FCS Press Releases

Florida Cancer Specialists & Research Institute, LLC (FCS) held a ribbon-cutting ceremony on August 18, 2022 to celebrate the opening of its newest clinical site in Pasco County.

Working collaboratively with Florida Cancer Specialists & Research Institute, LLC (FCS), NCODA, Inc. developed a more efficient way for healthcare professionals to expand their knowledge and share feedback about ongoing advancements.

An in-depth article authored by Florida Cancer Specialists & Research Institute, LLC (FCS) pharmacy experts published in the American Journal of Managed Care® (AJMC®) issues a call to action for the development of improved metrics to help lower costs and better assess the performance of pharmacies that dispense oral oncolytic medications. 

A collaboration between Florida Cancer Specialists & Research Institute, LLC (FCS) and Florida Blue, the state’s Blue Cross Blue Shield plan, is proving to enhance patient care and well-being while also keeping health care costs under control.

Florida Cancer Specialists & Research Institute, LLC (FCS) Fort Myers – Colonial lab team has met all the criteria for Laboratory Accreditation by COLA Inc., a leading national laboratory accreditor, whose program and standards enable clinical laboratories and staff to meet United States Clinical Laboratory Improvement Act (CLIA) and other regulatory requirements.

Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes two Board-certified medical oncologists to the statewide practice, expanding care for patients receiving treatment for cancer and blood disorders. Joining FCS on August 1, 2022 are Tony J. Kurian, MD (Sarasota County) and Wenqing Zhang, MD, PhD (Citrus County).

Rhone M. Levin, M.Ed., RDN, CSO, LDN, FCS clinical oncology dietitian, has been selected to speak at the Pathways to Prevention workshop hosted this month by the National Institutes of Health.

FCS announced the addition of precision oncology capabilities comprised of geneticists, informatics specialists, and database technologies. Enhancing care through molecular data analysis.

Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified medical oncologist Susanna Gaikazian, MD to the statewide practice.

Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes medical oncologist Mariuxi Viteri Malone, MD to the statewide practice. She is providing care to patients at FCS locations in Englewood, at 174 Doctors Drive, Englewood, FL 34223, at Venice Healthpark, 836 Sunset Lake Blvd., Suite 101, Venice, FL 34292 and on Venice Island, 901 S. Tamiami Trail, Venice, FL 34285.

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome Colleen Lewis, MSN, ANP-BC, AOCNP to its senior leadership team as Vice President of Nursing and Research.

Christopher Eliff, MHA, In-house Manager of Care Management for Florida Cancer Specialists & Research Institute, LLC (FCS), has been selected as a recipient of the 40 Under 40 in Cancer Award.

Florida Cancer Specialists & Research Institute, LLC (FCS) held a ribbon-cutting ceremony on June 16, 2022 to celebrate the opening of a new clinical site in Kissimmee, FL. Located at 801 W. Oak Street, Kissimmee, FL 34741, the 3,400 square foot office offers a broad range of treatments and services for patients with cancer and blood disorders, including medical oncology/hematology, infusions and an in-house laboratory.

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome Alexander Philipovskiy, MD, PhD as a principal investigator at the FCS Drug Development Unit in Lake Mary, FL, located at 805 Currency Circle, which is part of Sarah Cannon.   

Florida Cancer Specialists & Research Institute, LLC (FCS) is proud to announce that its oral oncolytic specialty pharmacy, Rx To Go, has earned URAC accreditation for Specialty Pharmacy.

Florida Cancer Specialists & Research Institute, LLS (FCS) physicians are presenting the outcomes of 33 clinical trials, at the 2022 ASCO® Meeting.